FDA inspects JJ Mahanagar Blood Bank in Byculla, orders inquiry
The Food and Drug Administration (FDA) has inspected the state-run JJ Mahanagar Blood Bank located within the JJ Hospital complex in Byculla, Mumbai, following a series of complaints. Along with the inspection, officials have ordered an inquiry into the facility's operations.
The blood bank was closed to the public while the inspection was being conducted. During the visit, teams of FDA officials scrutinised various records and documents at the blood bank. A senior FDA official stated that the findings of this inspection would be announced on Thursday.
The official inquiry was launched to investigate several allegations against the blood bank. Among the primary charges is that blood bags collected through voluntary blood donation drives were allegedly being supplied at subsidised rates to private blood banks.
State Blood Transfusion Council (SBTC) director Dr. Suhas Mohnalkar confirmed that he was awaiting the final report from the FDA. Dr. Mohnalkar noted that the FDA holds the authority to take action against blood banks. He also added that a separate inquiry into the complaints had already been initiated.
The JJ Mahanagar Blood Bank was established in 2009 with the specific goal of improving access to blood and blood products for economically weaker patients. Despite this mission, concerns have been raised about the functioning of the facility in recent years.
A former SBTC official, who requested anonymity, expressed concern over the situation, stating that patients within JJ Hospital itself do not get access to blood from this particular bank. The former official described the allegations that blood bags were diverted to private blood banks as shocking.
According to officials, the ongoing inquiry will examine these allegations in detail. The investigation aims to determine whether any violations of official blood banking regulations have occurred at the facility.
